Acceleron Pharma reported $-70465000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 3179M 2413M
Acceleron Pharma XLRN:US $ -70.46M 6.94M
Akebia Therapeutics AKBA:US $ -59.54M 23.49M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
Amgen AMGN:US $ 1884M 1420M
Arena Pharmaceuticals ARNA:US $ -196.31M 50.22M
Bayer BAYN:GR € 85M 2420M
Biomarin Pharmaceutical BMRN:US $ -36.49M 49.44M
Bluebird Bio BLUE:US $ -216.82M 24.89M
Clovis Oncology CLVS:US $ -67.41M 0.96M
Dicerna Pharmaceuticals DRNA:US $ -17.07M 23.74M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Exelixis EXEL:US $ 38.2M 57.89M
Gilead Sciences GILD:US $ 2592M 1070M
GlaxoSmithKline GSK:LN 1168M 227M
Johnson & Johnson JNJ:US $ 3667M 2611M
Karyopharm Therapeutics KPTI:US $ -51812000 1.77M
Mirati Therapeutics MRTX:US $ -80.05M 86.38M
Neurocrine Biosciences NBIX:US $ 22.5M 19.8M
Novartis NOVN:VX SF 2758M 138M
Pfizer PFE:US $ 8146M 2582M
Ptc Therapeutics PTCT:US $ -133.62M 15.25M
Puma Biotechnology PBYI:US $ -44.67M 39.57M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M
Rigel Pharmaceuticals RIGL:US $ -20.95M 7.13M
Sangamo Biosciences SGMO:US $ -47.69M 0.52M
Tg Therapeutics TGTX:US $ -85.64M 7.14M
Ultragenyx Pharmaceutical RARE:US $ -73M 49.43M
United Therapeutics UTHR:US $ 162.7M 9.9M
Vertex Pharmaceuticals VRTX:US $ 851.93M 785M